Antagonism of Transforming Growth Factor-Β Signaling Inhibits Fibrosis-Related Genes
Article
Received:
Revised:
Accepted:
- 103 Downloads
- 5 Citations
Abstract
In the fibrotic process, the transforming growth factor-β1 (TGF-β1)/Smad3 (Sma- and Mad-related protein␣3) signaling plays a central role. To screen for antagonists of TGF-β1/Smad3 signaling and to investigate their effects on the genes related to fibrosis, we construct a molecular model with a luciferase reporter gene. Results showed that both SB-431542 [4-(5-benzo[1,3]dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)-benzamide] and small interference RNA (siRNA) against Smad3 could dose-dependently suppress the reporter gene. More importantly, they both significantly inhibited the expression of plasminogen activator inhibitor-type 1 (PAI-1) and type I collagenα1 (Col Iα1) genes in rat hepatic stellate cells. Thus, SB-431542 and Smad3/siRNA may be potential therapeutics for fibrosis.
Keywords
fibrosis siRNA Smad3 protein transforming growth factor-β1Preview
Unable to display preview. Download preview PDF.
References
- Blokzijl, A, Dahlqvist, C, Reissmann, E, Falk, A, Moliner, A, Lendahl, U, Ibanez, CF 2003Cross-talk between the Notch and TGF-β signaling pathways mediated by interaction of the Notch intracellular domain with Smad3J. Cell Biol.163723728CrossRefPubMedGoogle Scholar
- Border, WA, Noble, NA 1994Transforming growth factor β in tissue fibrosisN. Engl. J. Med.33112861292CrossRefPubMedGoogle Scholar
- Callahan, JF, Burgess, JL, Fornwald, JA, Gaster, LM, Harling, JD, Harrington, FP, Heer, J, Kwon, C, Lehr, R, Mathur, A, Olson, BA, Weinstock, J, Laping, NJ 2002Identification of novel inhibitors of the transforming growth factor-β1 (TGF-β1) type I receptor (ALK5)J. Med. Chem.459991001CrossRefPubMedGoogle Scholar
- DaCosta Byfield, S, Major, C, Laping, NJ, Roberts, AB 2004SB-505124 is a selective inhibitor of transforming growth factor-β type receptors ALK4, ALK5, and ALK7Mol. Pharmacol.65744752CrossRefPubMedGoogle Scholar
- Dennler, S, Itoh, S, Vivien, D, ten Dijke, P, Huet, S, Gauthier, JM 1998Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 geneEMBO J.1730913100CrossRefPubMedGoogle Scholar
- Flanders, KC 2004Smad3 as a mediator of the fibrotic responseInt. J. Exp. Path.854764CrossRefGoogle Scholar
- Friedman, SL 2000Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injuryJ. Biol. Chem.27522472250CrossRefPubMedGoogle Scholar
- George, J, Roulot, D, Koteliansky, VE, Bissell, DM 1999In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: a potential new therapy for hepatic fibrosisProc. Natl. Acad. Sci. USA961271912724CrossRefPubMedGoogle Scholar
- Hui, AY, Friedman, SL 2003Molecular basis of hepatic fibrosisExp. Rev. Mol. Med.5123CrossRefGoogle Scholar
- Inman, GJ, Nicolas, FJ, Callahan, JF, Harling, JD, Gaster, LM, Reith, AD, Laping, NJ, Hill, CS 2002SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7Mol. Pharmacol.626574CrossRefPubMedGoogle Scholar
- Johnsen, SA, Subramaniam, M, Katagiri, T, Janknecht, R, Spelsberg, TC 2002Transcriptional regulation of Smad2 is required for enhancement of TGFβ/Smad signaling by TGFβ inducible early geneJ. Cell Biochem.87233241CrossRefPubMedGoogle Scholar
- Laping, NJ, Grygielko, E, Mathur, A, Butter, S, Bomberger, J, Tweed, C, Martin, W, Fornwald, J, Lehr, R, Harling, J, Gaster, L, Callahan, JF, Olson, BA 2002Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542Mol. Pharmacol.625864CrossRefPubMedGoogle Scholar
- Massague, J, Blain, SW, Lo, RS 2000TGFβ signaling in growth control, cancer, and heritable disordersCell103295309CrossRefPubMedGoogle Scholar
- Nakamura, T, Sakata, R, Ueno, T, Sata, M, Ueno, H 2000Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated ratsHepatology32247255CrossRefPubMedGoogle Scholar
- Ohshima, T, Suganuma, T, Ikeda, M 2001A novel mutation lacking the bromodomain of the transcriptional coactivator p300 in the SiHa cervical carcinoma cell lineBiochem. Biophys. Res. Commun.281569575CrossRefPubMedGoogle Scholar
- Ota, T, Fujii, M, Sugizaki, T, Ishii, M, Miyazawa, K, Aburatani, H, Miyazono, K 2002Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-β in human umbilical vein endothelial cellsJ. Cell Physiol.193299318CrossRefPubMedGoogle Scholar
- Roberts, AB, Sporn, MB 1993Physiological actions and clinical applications of transforming growth factor-β (TGF-β)Growth Factors819PubMedGoogle Scholar
- Schnabl, B, Kweon, YO, Frederick, JP, Wang, XF, Rippe, RA, Brenner, DA 2001The role of Smad3 in mediating mouse hepatic stellate cell activationHepatology3489100CrossRefPubMedGoogle Scholar
- Suganuma, T, Kawabata, M, Ohshima, T, Ikeda, MA 2002Growth suppression of human carcinoma cells by reintroduction of the p300 coactivatorProc. Natl. Acad. Sci. USA991307313078CrossRefPubMedGoogle Scholar
- Tan, FL, Yin, JQ 2005Application of RNAi to cancer research and therapyFront. Biosci.1019461960PubMedGoogle Scholar
- ten Dijke, P, Hill, CS 2004New insights into TGF-β-Smad signalingTrends Biochem. Sci.29265273CrossRefPubMedGoogle Scholar
- Verrecchia, F, Chu, ML, Mauviel, A 2001Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approachJ. Biol. Chem.2761705817062CrossRefPubMedGoogle Scholar
- Yeom, SY, Jeoung, D, Ha, KS, Kim, PH 2004Small interfering RNA (siRNA) targeted to Smad3 inhibits transforming growth factor-β signalingBiotech. Lett.26699703CrossRefGoogle Scholar
- Yin, JQ, Wang, Y 2002siRNA-mediated gene regulation system: now and the futureInt. J. Mol. Med. Mar.10355365Google Scholar
Copyright information
© Springer 2005